Clinical Trial Update: Evaluation of Autologous Natural Killer Cell Activity in Primary Cancer Cell Cultures

View source ↗

Summary

A clinical trial evaluating autologous natural killer cell therapy in primary cancer cell cultures for sarcoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Drugs mentioned

• Autologous natural killer cell therapy (autologous natural killer cells)

Snippet

Sponsor: Sarcoma Oncology Research Center, LLC | Conditions: Sarcoma | Status: WITHDRAWN